Morning Plenary Session: National Patent Development Strategy (2011-2020)
8:20 - 8:50
Opening Remarks
8:50 - 9:20
Update on National Patent Development Strategy (2011-2020)
9:20 - 9:40
The America Invests Act
9:40 - 10:30
Patent Linkage Development in China
10:30 - 10:40
Tea Break
10:40 - 11:10
Patent Enforcement in China
11:10 - 11:40
European Patent With Unitary Effect
11:40 - 12:10
Discussion of the Role of Patents in Wealth Creation
12:10 - 13:30
Lunch Break & Social Networking
Afternoon Plenary Session: Capturing Inventions
13:30 –15: 45
Panel Presentation on Comparing Similarities and Differences in Patent Prosecution and Patent Scope in EU, US, and Asia
Panel presentations and discussion on
1) patenting pharmaceutical inventions and patent examination for the pharmaceutical, biotech and chemical industries
2) the differences of patent examination in different patent offices
Each presenter gives 25 min presentation on each jurisdiction presentations)
Questions at the end of whole presentation (total 15 min)
Chaired by
Introduction (5 min)
US (25 min)
EP (25 min)
China (25 min)
KR (25 min)
Q&A (15 min)
15:45 - 16:00
Social Network & Exhibition Tour By CMC Leaders
16:00 - 17:50
Panel Presentations on Biological Drug Development in EU, US, JP and CH
Panel presentations and discussion on
1) Biotechnology patents and patent strategies
2) Review of biosimilar approval policy, legislation and implementation
Each presenter gives 25 min presentation on each jurisdiction
Questions at the end of whole presentation (total 10 min)
Chaired by
Introduction (5min)
The Biosimilars in USA(25 min)
FDA representative (25 min)
EP (25 min)
China (25 min)
Q&A(15 min)
Evening Program
18:30-21:30
Conference Sponsored Dinner
Saturday, May 26, 2012
Morning Plenary Session: Invention, Patent Transfer and Commercialization
8:30 – 10:30
Panel Presentations on Invention & Patent Transfer in the Key Jurisdictions EU, US, JP, and CH
Each presenter gives 20 min presentation on each jurisdiction
Questions at the end of whole presentation (total 10 min)
Chaired by
Introduction (5 min)
Frontier R&D in China (25 min)
Establishing and managing R&D innovation as a global pharmaceutical company in Asia Pacific Region (25 min)
Innovation & tech transfer in US (25 min)
China Medical City: an incubation for R&D and research based companies (20 min)
Q&A (15 min)
10:30: - 10:45
Social Network and Tea Break
10:45- 11:20
Global Pharmaceutical In- and out-license strategies
11:25 - 12:00
Strategies of Building and Managing Patent Portfolio
12:00 - 13:30
Lunch Break & Social Networking
Afternoon Plenary Session: Invention Enforcement
13:30 – 15:30
Panel Presentations & Discussions on Comparing Similarities and Differences in Patent Enforcement in the Key Jurisdictions by Showing How Patent Litigation Works in Those Jurisdictions.
Each presenter gives 25 min presentation on each jurisdiction
Questions at the end of whole presentation (total 15 min)
Chaired by
Introduction (5 min)
Overview of Recent Developments in Patent Litigation in the U.S(25 min)
Pharmaceutical Patent Litigation in the U.S. under the Hatch-Waxman Act (25 min)
European Patent Litigation Related to Pharmaceutical Products (25 min)
Patent Litigation and Procedure in China (25 min)
Q&A (15 min)
15:30- 15:45
Social Network and Tea Break
15: 45- 16:25
Current Trends in Patent Protection and Litigation in China
16: 25- 17:05
The Balance and Challenge of Open Innovation and IP Protection
17: 05- 17:45
Worldwide Patent Enforcement Strategies
Evening Program
18:00-21:00
Conference Sponsored Dinner
Sunday, May 27, 2012
Morning Plenary Session: China Patent Examination and Patent Invalidation Proceedings
8:30 - 11:30
China Program - Roundtable Discussion
Hot Issues on Patent Procurement and Enforcement in China
Moderator: Ningling Wang, Partner of Finnegan
Panelists:
One judge from Beijing Intermediate No. 1 People’s Court (TBD)
One judge from local Jiangsu court (TBD)
Mr. Guiming Liu (Deputy Director of Chemical Group) (TBC)
Ms. Amy Feng (Partner, Liu Shen) (TBC)
Mr. David Shen (IP counsel, AstraZeneca) (TBC)
Mr. Yang Xu (IP director, Simcere) (TBC)
11:30 – 12:00
Closing Remarks
12:00 -14:30
Social Networking and Lunch Break
Afternoon: Special Program
• Round Table Discussion With CMC Research Companies & Decision Makers